Everything we've seen

1. ·Nov 15, 11:19 AMstreamnews

   Corteva Inc. (CTVA) Falls Harder Than Wall Street — Here’s Why

   Corteva Inc. (NYSE:CTVA) is one of the 10 Stocks Underperforming the Broader Market. Corteva fell by 24.30 percent on Thursday to close at $9.19 apiece, as investor sentiment was dampened by the company’s cautious outlook, leading to lower annual growth guidance for the rest of the year. In an earnings call, Corteva Inc. (NYSE:CTVA) CEO […]

2. ·Nov 15, 11:19 AMstreamnews

   Corteva (CTVA) Cuts Guidance And Delays Filing, Is The Reset Now Fully Priced In?

   Corteva (CTVA) is back in focus after a sharp guidance reset and a 23% share price drop, with investors now weighing weaker Brazil conditions, fresh legal risk, and a delayed quarterly SEC filing. The sharp guidance cut, delayed 10-Q and fresh chlorpyrifos lawsuit have all hit sentiment at once, and the share price has reacted hard. Corteva’s stock is down 24.3% on a 1-day share price return basis and 31.4% over the past month. This leaves the year-to-date share price return down 26.9% and...

3. ·Nov 15, 11:19 AMstreamnews

   Corteva Q3 Earnings Call Highlights

   Corteva (NYSE:CTVA) lowered its full-year earnings outlook after a sharp deterioration in Brazil’s agricultural market and elevated inventories in the distribution channel outweighed growth in other regions. The company now expects 2026 adjusted pro forma operating EBITDA of $1.1 billion to $1.125

4. ·Nov 15, 11:19 AMstreamnews

   Has Corteva (CTVA) Fallen Enough To Offset Its Earnings Premium?

   Corteva has just seen a sharp reset in its share price, and the slide is forcing investors to ask whether the current valuation still lines up with what the business is earning. After a series of earnings-related headlines and a steep selloff, the key issue is how much profit power the market is actually paying for today. The stock has fallen 31.4% over the past month, which puts the spotlight firmly on whether that move now matches the strength and trajectory of Corteva’s earnings. Recent...

5. ·Nov 15, 11:19 AMstreamnews

   RBC Capital Maintains Outperform on Corteva, Lowers Price Target to $11

   RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.

6. ·Nov 15, 11:19 AMstreamnews

   UBS Maintains Neutral on Corteva, Lowers Price Target to $10

   UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.

7. ·Nov 15, 11:19 AMstreamnews

   Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut

   CTVA cuts its 2026 profit outlook as Brazil's inventory glut and pricing pressures weigh on results, while new products and cost cuts support recovery plans.

8. ·Nov 15, 11:19 AMstreamnews

   JP Morgan Maintains Overweight on Corteva, Lowers Price Target to $16

   JP Morgan analyst Jeffrey Zekauskas maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $19 to $16.

9. ·Nov 15, 11:04 AMstreamnews

   Corteva Inc. (CTVA) Falls Harder Than Wall Street — Here’s Why

   Corteva Inc. (NYSE:CTVA) is one of the 10 Stocks Underperforming the Broader Market. Corteva fell by 24.30 percent on Thursday to close at $9.19 apiece, as investor sentiment was dampened by the company’s cautious outlook, leading to lower annual growth guidance for the rest of the year. In an earnings call, Corteva Inc. (NYSE:CTVA) CEO […]

10. ·Nov 15, 11:04 AMstreamnews

    Corteva (CTVA) Cuts Guidance And Delays Filing, Is The Reset Now Fully Priced In?

    Corteva (CTVA) is back in focus after a sharp guidance reset and a 23% share price drop, with investors now weighing weaker Brazil conditions, fresh legal risk, and a delayed quarterly SEC filing. The sharp guidance cut, delayed 10-Q and fresh chlorpyrifos lawsuit have all hit sentiment at once, and the share price has reacted hard. Corteva’s stock is down 24.3% on a 1-day share price return basis and 31.4% over the past month. This leaves the year-to-date share price return down 26.9% and...

11. ·Nov 15, 11:04 AMstreamnews

    Corteva Q3 Earnings Call Highlights

    Corteva (NYSE:CTVA) lowered its full-year earnings outlook after a sharp deterioration in Brazil’s agricultural market and elevated inventories in the distribution channel outweighed growth in other regions. The company now expects 2026 adjusted pro forma operating EBITDA of $1.1 billion to $1.125

12. ·Nov 15, 11:04 AMstreamnews

    Has Corteva (CTVA) Fallen Enough To Offset Its Earnings Premium?

    Corteva has just seen a sharp reset in its share price, and the slide is forcing investors to ask whether the current valuation still lines up with what the business is earning. After a series of earnings-related headlines and a steep selloff, the key issue is how much profit power the market is actually paying for today. The stock has fallen 31.4% over the past month, which puts the spotlight firmly on whether that move now matches the strength and trajectory of Corteva’s earnings. Recent...

13. ·Nov 15, 11:04 AMstreamnews

    RBC Capital Maintains Outperform on Corteva, Lowers Price Target to $11

    RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.

14. ·Nov 15, 11:04 AMstreamnews

    UBS Maintains Neutral on Corteva, Lowers Price Target to $10

    UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.

15. ·Nov 15, 11:04 AMstreamnews

    Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut

    CTVA cuts its 2026 profit outlook as Brazil's inventory glut and pricing pressures weigh on results, while new products and cost cuts support recovery plans.

16. ·Nov 15, 11:04 AMstreamnews

    JP Morgan Maintains Overweight on Corteva, Lowers Price Target to $16

    JP Morgan analyst Jeffrey Zekauskas maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $19 to $16.

17. ·Nov 15, 10:49 AMstreamnews

    Corteva Inc. (CTVA) Falls Harder Than Wall Street — Here’s Why

    Corteva Inc. (NYSE:CTVA) is one of the 10 Stocks Underperforming the Broader Market. Corteva fell by 24.30 percent on Thursday to close at $9.19 apiece, as investor sentiment was dampened by the company’s cautious outlook, leading to lower annual growth guidance for the rest of the year. In an earnings call, Corteva Inc. (NYSE:CTVA) CEO […]

18. ·Nov 15, 10:49 AMstreamnews

    Corteva (CTVA) Cuts Guidance And Delays Filing, Is The Reset Now Fully Priced In?

    Corteva (CTVA) is back in focus after a sharp guidance reset and a 23% share price drop, with investors now weighing weaker Brazil conditions, fresh legal risk, and a delayed quarterly SEC filing. The sharp guidance cut, delayed 10-Q and fresh chlorpyrifos lawsuit have all hit sentiment at once, and the share price has reacted hard. Corteva’s stock is down 24.3% on a 1-day share price return basis and 31.4% over the past month. This leaves the year-to-date share price return down 26.9% and...

19. ·Nov 15, 10:49 AMstreamnews

    Corteva Q3 Earnings Call Highlights

    Corteva (NYSE:CTVA) lowered its full-year earnings outlook after a sharp deterioration in Brazil’s agricultural market and elevated inventories in the distribution channel outweighed growth in other regions. The company now expects 2026 adjusted pro forma operating EBITDA of $1.1 billion to $1.125

20. ·Nov 15, 10:49 AMstreamnews

    Has Corteva (CTVA) Fallen Enough To Offset Its Earnings Premium?

    Corteva has just seen a sharp reset in its share price, and the slide is forcing investors to ask whether the current valuation still lines up with what the business is earning. After a series of earnings-related headlines and a steep selloff, the key issue is how much profit power the market is actually paying for today. The stock has fallen 31.4% over the past month, which puts the spotlight firmly on whether that move now matches the strength and trajectory of Corteva’s earnings. Recent...

21. ·Nov 15, 10:49 AMstreamnews

    RBC Capital Maintains Outperform on Corteva, Lowers Price Target to $11

    RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.

22. ·Nov 15, 10:49 AMstreamnews

    UBS Maintains Neutral on Corteva, Lowers Price Target to $10

    UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.

23. ·Nov 15, 10:49 AMstreamnews

    Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut

    CTVA cuts its 2026 profit outlook as Brazil's inventory glut and pricing pressures weigh on results, while new products and cost cuts support recovery plans.

24. ·Nov 15, 10:34 AMstreamnews

    Corteva Inc. (CTVA) Falls Harder Than Wall Street — Here’s Why

    Corteva Inc. (NYSE:CTVA) is one of the 10 Stocks Underperforming the Broader Market. Corteva fell by 24.30 percent on Thursday to close at $9.19 apiece, as investor sentiment was dampened by the company’s cautious outlook, leading to lower annual growth guidance for the rest of the year. In an earnings call, Corteva Inc. (NYSE:CTVA) CEO […]

25. ·Nov 15, 10:34 AMstreamnews

    Corteva (CTVA) Cuts Guidance And Delays Filing, Is The Reset Now Fully Priced In?

    Corteva (CTVA) is back in focus after a sharp guidance reset and a 23% share price drop, with investors now weighing weaker Brazil conditions, fresh legal risk, and a delayed quarterly SEC filing. The sharp guidance cut, delayed 10-Q and fresh chlorpyrifos lawsuit have all hit sentiment at once, and the share price has reacted hard. Corteva’s stock is down 24.3% on a 1-day share price return basis and 31.4% over the past month. This leaves the year-to-date share price return down 26.9% and...

26. ·Nov 15, 10:34 AMstreamnews

    Corteva Q3 Earnings Call Highlights

    Corteva (NYSE:CTVA) lowered its full-year earnings outlook after a sharp deterioration in Brazil’s agricultural market and elevated inventories in the distribution channel outweighed growth in other regions. The company now expects 2026 adjusted pro forma operating EBITDA of $1.1 billion to $1.125

27. ·Nov 15, 10:34 AMstreamnews

    Has Corteva (CTVA) Fallen Enough To Offset Its Earnings Premium?

    Corteva has just seen a sharp reset in its share price, and the slide is forcing investors to ask whether the current valuation still lines up with what the business is earning. After a series of earnings-related headlines and a steep selloff, the key issue is how much profit power the market is actually paying for today. The stock has fallen 31.4% over the past month, which puts the spotlight firmly on whether that move now matches the strength and trajectory of Corteva’s earnings. Recent...

28. ·Nov 15, 10:34 AMstreamnews

    RBC Capital Maintains Outperform on Corteva, Lowers Price Target to $11

    RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.

29. ·Nov 15, 10:34 AMstreamnews

    UBS Maintains Neutral on Corteva, Lowers Price Target to $10

    UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.

30. ·Nov 15, 10:34 AMstreamnews

    Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut

    CTVA cuts its 2026 profit outlook as Brazil's inventory glut and pricing pressures weigh on results, while new products and cost cuts support recovery plans.

31. ·Nov 15, 10:19 AMstreamnews

    Corteva Inc. (CTVA) Falls Harder Than Wall Street — Here’s Why

    Corteva Inc. (NYSE:CTVA) is one of the 10 Stocks Underperforming the Broader Market. Corteva fell by 24.30 percent on Thursday to close at $9.19 apiece, as investor sentiment was dampened by the company’s cautious outlook, leading to lower annual growth guidance for the rest of the year. In an earnings call, Corteva Inc. (NYSE:CTVA) CEO […]

32. ·Nov 15, 10:19 AMstreamnews

    Corteva (CTVA) Cuts Guidance And Delays Filing, Is The Reset Now Fully Priced In?

    Corteva (CTVA) is back in focus after a sharp guidance reset and a 23% share price drop, with investors now weighing weaker Brazil conditions, fresh legal risk, and a delayed quarterly SEC filing. The sharp guidance cut, delayed 10-Q and fresh chlorpyrifos lawsuit have all hit sentiment at once, and the share price has reacted hard. Corteva’s stock is down 24.3% on a 1-day share price return basis and 31.4% over the past month. This leaves the year-to-date share price return down 26.9% and...

33. ·Nov 15, 10:19 AMstreamnews

    Corteva Q3 Earnings Call Highlights

    Corteva (NYSE:CTVA) lowered its full-year earnings outlook after a sharp deterioration in Brazil’s agricultural market and elevated inventories in the distribution channel outweighed growth in other regions. The company now expects 2026 adjusted pro forma operating EBITDA of $1.1 billion to $1.125

34. ·Nov 15, 10:19 AMstreamnews

    Has Corteva (CTVA) Fallen Enough To Offset Its Earnings Premium?

    Corteva has just seen a sharp reset in its share price, and the slide is forcing investors to ask whether the current valuation still lines up with what the business is earning. After a series of earnings-related headlines and a steep selloff, the key issue is how much profit power the market is actually paying for today. The stock has fallen 31.4% over the past month, which puts the spotlight firmly on whether that move now matches the strength and trajectory of Corteva’s earnings. Recent...

35. ·Nov 15, 10:19 AMstreamnews

    RBC Capital Maintains Outperform on Corteva, Lowers Price Target to $11

    RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.

36. ·Nov 15, 10:19 AMstreamnews

    UBS Maintains Neutral on Corteva, Lowers Price Target to $10

    UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.

37. ·Nov 15, 10:19 AMstreamnews

    Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut

    CTVA cuts its 2026 profit outlook as Brazil's inventory glut and pricing pressures weigh on results, while new products and cost cuts support recovery plans.

38. ·Nov 15, 10:04 AMstreamnews

    Corteva Inc. (CTVA) Falls Harder Than Wall Street — Here’s Why

    Corteva Inc. (NYSE:CTVA) is one of the 10 Stocks Underperforming the Broader Market. Corteva fell by 24.30 percent on Thursday to close at $9.19 apiece, as investor sentiment was dampened by the company’s cautious outlook, leading to lower annual growth guidance for the rest of the year. In an earnings call, Corteva Inc. (NYSE:CTVA) CEO […]

39. ·Nov 15, 10:04 AMstreamnews

    Corteva (CTVA) Cuts Guidance And Delays Filing, Is The Reset Now Fully Priced In?

    Corteva (CTVA) is back in focus after a sharp guidance reset and a 23% share price drop, with investors now weighing weaker Brazil conditions, fresh legal risk, and a delayed quarterly SEC filing. The sharp guidance cut, delayed 10-Q and fresh chlorpyrifos lawsuit have all hit sentiment at once, and the share price has reacted hard. Corteva’s stock is down 24.3% on a 1-day share price return basis and 31.4% over the past month. This leaves the year-to-date share price return down 26.9% and...

40. ·Nov 15, 10:04 AMstreamnews

    Corteva Q3 Earnings Call Highlights

    Corteva (NYSE:CTVA) lowered its full-year earnings outlook after a sharp deterioration in Brazil’s agricultural market and elevated inventories in the distribution channel outweighed growth in other regions. The company now expects 2026 adjusted pro forma operating EBITDA of $1.1 billion to $1.125

41. ·Nov 15, 10:04 AMstreamnews

    Has Corteva (CTVA) Fallen Enough To Offset Its Earnings Premium?

    Corteva has just seen a sharp reset in its share price, and the slide is forcing investors to ask whether the current valuation still lines up with what the business is earning. After a series of earnings-related headlines and a steep selloff, the key issue is how much profit power the market is actually paying for today. The stock has fallen 31.4% over the past month, which puts the spotlight firmly on whether that move now matches the strength and trajectory of Corteva’s earnings. Recent...

42. ·Nov 15, 10:04 AMstreamnews

    RBC Capital Maintains Outperform on Corteva, Lowers Price Target to $11

    RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.

43. ·Nov 15, 10:04 AMstreamnews

    UBS Maintains Neutral on Corteva, Lowers Price Target to $10

    UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.

44. ·Nov 15, 10:04 AMstreamnews

    Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut

    CTVA cuts its 2026 profit outlook as Brazil's inventory glut and pricing pressures weigh on results, while new products and cost cuts support recovery plans.

45. ?Nov 13, 7:30 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    CTVA (Corteva) is a fundamentally sound agricultural sciences company with a defensible business model in crop protection and seeds, but the 37.1% drop from its 30-day high to $9.19 is exceptionally severe and unexplained by any available evidence. No news headlines exist in the window, and the three 8-K filings lack financial metrics, leaving the cause of the drawdown entirely opaque — a large unexplained drop is itself a warning signal. The macro backdrop shows inflation expectations (T10YIE) running 1.7σ below trend, which is modestly constructive for long-duration assets but does not specifically benefit agricultural inputs companies.

46. !Nov 13, 7:30 PMsignalseverity 0.35

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    CTVA (Corteva) is a fundamentally sound agricultural sciences company with a defensible business model in crop protection and seeds, but the 37.1% drop from its 30-day high to $9.19 is exceptionally severe and unexplained by any available evidence. No news headlines exist in the window, and the three 8-K filings lack financial metrics, leaving the cause of the drawdown entirely opaque — a large unexplained drop is itself a warning signal. The macro backdrop shows inflation expectations (T10YIE) running 1.7σ below trend, which is modestly constructive for long-duration assets but does not specifically benefit agricultural inputs companies.

47. ?Nov 13, 5:21 PMdecisionconsidered

    Agent 20 — SIR Price/Volume — skip

    [distribution] The 20-day PV path tells a clear bearish story well before today's catastrophic print. From Oct 19 through Oct 28, the path drifted steadily down-and-right — six consecutive DOWN days (Oct 21–28) on volumes ranging 14.7M–21.9M, with closes collapsing from $12.86 to $11.33 — a classic distribution drift. A brief attempted recovery (Oct 29 – Nov 4, culminating in a $12.26 close on 51.3M+ combined volume on Nov 4) was immediately rejected: Nov 5–6 saw down days on elevated volume (26.4M on Nov 6 alone), confirming supply re-emerging. The climax arrived on 2026-11-12: a -24.30% crash on 64.9M shares — nearly 3× the 20-day ADV of 22.3M — breaking the entire prior cluster (which had ranged $11.33–$12.90) in a single session. Today's 2026-11-13 bar (+2.61%, 51.3M) is a high-volume dead-cat bounce still far below the broken cluster, not a bullish path development. The overall 20-day path shows an unambiguous down-and-right drift meeting all three bearish confirmation criteria: (1) the Nov 12 bar is a multi-week low on 2.91× ADV volume; (2) the last 3-session sub-path (Nov 11 flat, Nov 12 -24.3%, Nov 13 +2.61%) shows net deeply negative price on massively expanding volume; and (3) the entire 20-day path drifts from $12.65 to $9.43 — down-and-right. Risks: This bearish read would be invalidated if today's UP bar on 51.3M volume (z-score 2.51) marks a true capitulation low, with the next 2–3 sessions holding above $9.19 on declining volume — suggesting the Nov 12 event was a one-time fundamental shock (e.g., earnings/guidance cut) now fully discounted. A close back above the broken cluster floor of ~$11.33 on strong volume would fully negate the distribution label.

48. ?Nov 13, 3:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

49. !Nov 13, 3:20 PMsignalseverity 0.36

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

50. ?Nov 13, 2:21 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

51. !Nov 13, 2:21 PMsignalseverity 0.36

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

52. ✓Nov 13, 1:23 PMdecisionacted

    Agent 5 — Dip Buyer (Evolving) — decide: buy

    CTVA is down 37.1% from its 30-day high — a very large drop that, absent confirmed fundamental deterioration, is a strong mean-reversion candidate (+1). The options flow is notably bullish: call volume z-score of 10.22 versus a put z-score of 2.82, with a P/C ratio of only 0.34, flagged as UNUSUAL — a classic informed-buying signal on a dipping stock (+1). Earnings are 80 days away, well outside the veto window, providing a clean runway (+1). No hard veto conditions were triggered: no imminent earnings, no disclosed fundamental impairment in the 10-Q/8-K filings (metrics empty, no going-concern or guidance-cut language visible), and no sector-plus-macro simultaneous freefall. Offsetting negatives include the high 10Y yield at 4.98% (-1), which is a structural headwind, and the lack of insider buying activity (-0, neutral rather than a negative cluster sale). The sector (Materials/XLB) is a middling performer (rank 7 of 11) with mixed signals. Net signal score: approximately +2, supporting a marginal buy.

53. ?Nov 13, 1:23 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

54. !Nov 13, 1:23 PMsignalseverity 0.37

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

55. ?Nov 13, 11:36 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

56. !Nov 13, 11:36 AMsignalseverity 0.36

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

57. ❖Nov 13, 10:57 AMnewsvia finnhub

    JP Morgan Maintains Overweight on Corteva, Lowers Price Target to $16

    JP Morgan analyst Jeffrey Zekauskas maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $19 to $16.

58. ❖Nov 13, 9:00 AMnewsvia finnhub

    Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut

    CTVA cuts its 2026 profit outlook as Brazil's inventory glut and pricing pressures weigh on results, while new products and cost cuts support recovery plans.

59. ❖Nov 13, 7:55 AMnewsvia finnhub

    UBS Maintains Neutral on Corteva, Lowers Price Target to $10

    UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.

60. ❖Nov 13, 6:23 AMnewsvia finnhub

    RBC Capital Maintains Outperform on Corteva, Lowers Price Target to $11

    RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.

61. ❖Nov 13, 6:16 AMnewsvia finnhub

    Has Corteva (CTVA) Fallen Enough To Offset Its Earnings Premium?

    Corteva has just seen a sharp reset in its share price, and the slide is forcing investors to ask whether the current valuation still lines up with what the business is earning. After a series of earnings-related headlines and a steep selloff, the key issue is how much profit power the market is actually paying for today. The stock has fallen 31.4% over the past month, which puts the spotlight firmly on whether that move now matches the strength and trajectory of Corteva’s earnings. Recent...

62. ❖Nov 13, 12:14 AMnewsvia finnhub

    Corteva Q3 Earnings Call Highlights

    Corteva (NYSE:CTVA) lowered its full-year earnings outlook after a sharp deterioration in Brazil’s agricultural market and elevated inventories in the distribution channel outweighed growth in other regions. The company now expects 2026 adjusted pro forma operating EBITDA of $1.1 billion to $1.125

63. ❖Nov 12, 10:14 PMnewsvia finnhub

    Corteva (CTVA) Cuts Guidance And Delays Filing, Is The Reset Now Fully Priced In?

    Corteva (CTVA) is back in focus after a sharp guidance reset and a 23% share price drop, with investors now weighing weaker Brazil conditions, fresh legal risk, and a delayed quarterly SEC filing. The sharp guidance cut, delayed 10-Q and fresh chlorpyrifos lawsuit have all hit sentiment at once, and the share price has reacted hard. Corteva’s stock is down 24.3% on a 1-day share price return basis and 31.4% over the past month. This leaves the year-to-date share price return down 26.9% and...

64. ❖Nov 12, 8:19 PMnewsvia finnhub

    Corteva Inc. (CTVA) Falls Harder Than Wall Street — Here’s Why

    Corteva Inc. (NYSE:CTVA) is one of the 10 Stocks Underperforming the Broader Market. Corteva fell by 24.30 percent on Thursday to close at $9.19 apiece, as investor sentiment was dampened by the company’s cautious outlook, leading to lower annual growth guidance for the rest of the year. In an earnings call, Corteva Inc. (NYSE:CTVA) CEO […]

65. ?Nov 12, 7:30 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    CTVA (Corteva) is a fundamentally sound agricultural sciences company with a defensible business model in crop protection and seeds, but the 37.1% drop from its 30-day high to $9.19 is exceptionally severe and unexplained by any available evidence. No news headlines exist in the window, and the three 8-K filings lack financial metrics, leaving the cause of the drawdown entirely opaque — a large unexplained drop is itself a warning signal. The macro backdrop shows inflation expectations (T10YIE) running 1.7σ below trend, which is modestly constructive for long-duration assets but does not specifically benefit agricultural inputs companies.

66. !Nov 12, 7:30 PMsignalseverity 0.37

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    CTVA (Corteva) is a fundamentally sound agricultural sciences company with a defensible business model in crop protection and seeds, but the 37.1% drop from its 30-day high to $9.19 is exceptionally severe and unexplained by any available evidence. No news headlines exist in the window, and the three 8-K filings lack financial metrics, leaving the cause of the drawdown entirely opaque — a large unexplained drop is itself a warning signal. The macro backdrop shows inflation expectations (T10YIE) running 1.7σ below trend, which is modestly constructive for long-duration assets but does not specifically benefit agricultural inputs companies.

67. ?Nov 12, 5:21 PMdecisionconsidered

    Agent 20 — SIR Price/Volume — skip

    [exhaustion] The 20-day PV path shows a gradual recovery rally from a trough around $11.33 (2026-10-28) up to $12.26 (2026-11-04) on modest, unremarkable volume — a benign-looking drift. Today's final dot (2026-11-12) violently breaks that path: the close collapses to $9.19 (-24.30%) on 88.1M shares — a volume z-score of +11.95σ above the trailing 20-day ADV of 19.7M, representing more than 4.5× normal daily volume. In SIR 2-D space, this single bar leaps far down-and-right from the prior cluster ($11.33–$12.26, 11.6M–32.5M volume), creating an unmistakable climactic distribution/exhaustion signature: extreme price collapse on unprecedented volume, the path's sharpest and most extreme move in the entire window. Risks: The exhaustion label could be wrong if today's catastrophic volume represents a one-time event-driven capitulation (e.g., earnings shock, litigation, sector news) that attracts bottom-fishers — in that case, a high-volume reversal over the next 1-3 sessions would invalidate the bearish read. Additionally, the macro context (T10YIE at 2.2, 1.7σ below trend) may suppress long-duration sector headwinds and accelerate a snap-back if the fundamental catalyst proves transient.

68. ❖Nov 12, 4:31 PMnewsvia finnhub

    Corteva Inc (CTVA) Q3 2026 Earnings Call Transcript

    Brazil weakness drives a guidance cut as Corteva overhauls its cost structure.

69. ?Nov 12, 2:36 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    CTVA is down 33.3% from its 30-day high with no visible fundamental catalyst in the SEC filings (three 8-Ks with empty metrics) and no news headlines to explain the drop. Signal scoring: the large drop magnitude (≥15%) earns +1, no earnings within 30 days (+1), and the sector has outperformed SPY by +9.24pts over 30 days which makes this an idiosyncratic single-stock drop (-1). Put volume z-score (1.52) is elevated relative to call volume z-score (0.53), suggesting informed hedging/bearish positioning (-1). The 10Y yield at 4.88% is a structural headwind (-1). No insider buying (0), no cluster buy signal (0). Net score: -1, which per the framework warrants skipping. The absence of any explanatory headlines or filing disclosures is concerning rather than reassuring — the sharp drop in a sector that is otherwise outperforming strongly suggests an idiosyncratic, undisclosed negative development. At $9.75 with consensus EPS of $0.27 for next quarter, the stock appears deeply discounted on the surface, but the opaque cause of the sell-off and negative options flow prevent a confident buy thesis.

70. !Nov 12, 2:36 PMsignalseverity 0.33

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    CTVA is down 33.3% from its 30-day high with no visible fundamental catalyst in the SEC filings (three 8-Ks with empty metrics) and no news headlines to explain the drop. Signal scoring: the large drop magnitude (≥15%) earns +1, no earnings within 30 days (+1), and the sector has outperformed SPY by +9.24pts over 30 days which makes this an idiosyncratic single-stock drop (-1). Put volume z-score (1.52) is elevated relative to call volume z-score (0.53), suggesting informed hedging/bearish positioning (-1). The 10Y yield at 4.88% is a structural headwind (-1). No insider buying (0), no cluster buy signal (0). Net score: -1, which per the framework warrants skipping. The absence of any explanatory headlines or filing disclosures is concerning rather than reassuring — the sharp drop in a sector that is otherwise outperforming strongly suggests an idiosyncratic, undisclosed negative development. At $9.75 with consensus EPS of $0.27 for next quarter, the stock appears deeply discounted on the surface, but the opaque cause of the sell-off and negative options flow prevent a confident buy thesis.

71. ❖Nov 12, 2:17 PMnewsvia finnhub

    Corteva's Core Profitability Miss, Outlook Cut Spell Trouble, Analysts Say

    Corteva's (CTVA) core profitability miss in the third quarter and full-year outlook reduction amid p

72. ❖Nov 12, 1:51 PMnewsvia finnhub

    Why Corteva Stock Dropped on Thursday

    FMC warned you: And now Corteva has missed earnings, too.

73. ❖Nov 12, 11:57 AMnewsvia finnhub

    Corteva's Q3 Earnings Miss Estimates on Brazil Weakness, Sales Lag

    CTVA's Q3 results miss estimates as Brazil weakness, competitive pricing and lower volumes pressure sales and earnings, prompting a 2026 outlook update.

74. ?Nov 12, 10:20 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

75. !Nov 12, 10:20 AMsignalseverity 0.37

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CTVA is down 36.7% from its 30-day high with no news headlines, no insider buying, and no clear explanation for the sharp drop — the cause is unknown, which cuts both ways. The 8-K filings contain no metrics, offering no insight into whether this is a fundamental impairment or a temporary dislocation. Options flow shows mildly elevated put volume (z=1.52) relative to calls (z=0.53), with a P/C ratio of 0.60 — not panicked, but not confirming informed bullish conviction either. The sector (Materials/XLB) has actually shown 30-day outperformance vs. SPY (+9.24pts), meaning CTVA's drop is likely idiosyncratic rather than sector-driven, which is a yellow flag without an identifiable catalyst. The macro environment is modestly challenging with VIX at the 76th percentile and the 10Y at 4.88%, adding a moderate headwind for a commodity-linked name.

76. ?Nov 12, 10:20 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    CTVA has dropped a severe 36.7% from its 30-day high to $9.25, which is an extreme move suggesting possible idiosyncratic fundamental impairment rather than sector noise. However, the evidence base is critically thin: three 8-Ks filed with no reported metrics, no news headlines, no insider activity, and no clear explanation for the collapse. The options flow shows elevated put z-score (1.52 vs call z-score 0.53), suggesting informed bearish positioning on this dipping stock. The sector (Materials/XLB) has actually outperformed the market meaningfully on a 30-day basis (+9.24pts vs SPY), making this a single-stock idiosyncratic drop — a strongly negative signal. With VIX at the 76th percentile, an elevated 10Y yield of 4.88%, and a risk-off broad market tone today, the macro backdrop adds further headwinds.

77. !Nov 12, 10:20 AMsignalseverity 0.37

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    CTVA has dropped a severe 36.7% from its 30-day high to $9.25, which is an extreme move suggesting possible idiosyncratic fundamental impairment rather than sector noise. However, the evidence base is critically thin: three 8-Ks filed with no reported metrics, no news headlines, no insider activity, and no clear explanation for the collapse. The options flow shows elevated put z-score (1.52 vs call z-score 0.53), suggesting informed bearish positioning on this dipping stock. The sector (Materials/XLB) has actually outperformed the market meaningfully on a 30-day basis (+9.24pts vs SPY), making this a single-stock idiosyncratic drop — a strongly negative signal. With VIX at the 76th percentile, an elevated 10Y yield of 4.88%, and a risk-off broad market tone today, the macro backdrop adds further headwinds.

78. ❖Nov 12, 10:14 AMnewsvia finnhub

    Corteva shares plunge 23% as earnings miss and weaker Brazil demand force guidance cut

    Corteva Inc (NYSE:CTVA) shares plunged 23% to $9.40 after the agricultural chemicals group missed third-quarter earnings and revenue expectations and cut its full-year 2026 guidance. Adjusted operating earnings fell short of analysts' expectations, coming in at $0.06 per share against a...

79. ?Nov 12, 9:20 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

80. ?Nov 12, 9:20 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

81. !Nov 12, 9:20 AMsignalseverity 0.17

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

82. !Nov 12, 9:20 AMsignalseverity 0.17

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

83. ❖Nov 12, 9:00 AMnewsvia finnhub

    Corteva, Inc. 2026 Q3 - Results - Earnings Call Presentation

    2026-11-12. The following slide deck was published by Corteva, Inc.

84. ❖Nov 12, 8:59 AMnewsvia finnhub

    Corteva, Inc. (CTVA) Q3 2026 Earnings Call Transcript

    Corteva, Inc. (CTVA) Q3 2026 Earnings Call November 12, 2026 10:30 AM ESTCompany ParticipantsRafael SoaresLuther Kissam - CEO & DirectorJeffrey Rudolph...

85. ❖Nov 12, 8:30 AMnewsvia finnhub

    Corteva, Inc. Q3 2026 Earnings Call Summary

    Moby summary of Corteva, Inc.'s Q3 2026 earnings call

86. ❖Nov 12, 8:07 AMnewsvia finnhub

    Corteva Stock’s Wild Ride Continues. This Time, Blame Brazil.

    Corteva reported better-than-expected third-quarter earnings, but fourth-quarter guidance came up short.

87. ❖Nov 12, 4:05 AMnewsvia finnhub

    Corteva Posts Downbeat Q3 Results, Joins Nvidia, Alvotech And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

    U.S. futures were mixed as Corteva plunged 8% after missing earnings and sales estimates; Digi, Nvidia, quantum stocks and others also fell premarket.

88. ❖Nov 12, 1:45 AMnewsvia finnhub

    Corteva CEO Says Brazil Was 'Materially Weaker Than Anticipated'

    Corteva Q3 sales fall 9% to $1.59B on pricing pressure and Brazil slump; stock sinks to a 52-week low after weak guidance.

89. ❖Nov 12, 12:56 AMnewsvia finnhub

    Why Tetra Tech Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

    Tetra Tech shares jumped 8.5% after beating Q4 estimates; Children's Place surged 302%, while Wheeler REIT fell 35.3% premarket.

90. ?Nov 11, 7:31 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    CTVA (Corteva) is a fundamentally sound agricultural sciences company with a diversified seed and crop protection business, and there are no news headlines or SEC filings in the window indicating company-specific deterioration such as guidance cuts, accounting issues, or fraud. The 8-K filings contain no reported metrics, offering no clarity on what may have driven the ~18.6% drawdown from the 30-day high. The macro context highlights elevated mortgage rates (7.24%, 2.3σ above trend), which is more relevant to housing-sensitive sectors and does not directly pressure CTVA's agricultural business, leaving the cause of the drop somewhat ambiguous and potentially sentiment- or sector-rotation-driven.

91. !Nov 11, 7:31 PMsignalseverity 0.17

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    CTVA (Corteva) is a fundamentally sound agricultural sciences company with a diversified seed and crop protection business, and there are no news headlines or SEC filings in the window indicating company-specific deterioration such as guidance cuts, accounting issues, or fraud. The 8-K filings contain no reported metrics, offering no clarity on what may have driven the ~18.6% drawdown from the 30-day high. The macro context highlights elevated mortgage rates (7.24%, 2.3σ above trend), which is more relevant to housing-sensitive sectors and does not directly pressure CTVA's agricultural business, leaving the cause of the drop somewhat ambiguous and potentially sentiment- or sector-rotation-driven.

92. ❖Nov 11, 4:30 PMnewsvia finnhub

    Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

    Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the third quarter and nine months ended September 30, 2026.

93. ?Nov 11, 2:21 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

94. !Nov 11, 2:21 PMsignalseverity 0.17

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

95. ?Nov 11, 2:21 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

96. !Nov 11, 2:20 PMsignalseverity 0.17

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

97. ?Nov 11, 1:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

98. !Nov 11, 1:20 PMsignalseverity 0.18

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

99. ?Nov 11, 1:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

100. !Nov 11, 1:20 PMsignalseverity 0.18

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

101. ❖Nov 11, 12:34 PMnewsvia finnhub

     Corteva Q3 Adj. EPS $0.06 Misses $0.10 Estimate, Sales $1.590B Miss $1.764B Estimate

     Corteva (NYSE:CTVA) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.10 by 40 percent. This is a 126.09 percent increase over losses of $(0.23) per share from the same

102. ❖Nov 11, 12:33 PMnewsvia finnhub

     Corteva Sees FY2026 Adj EPS $0.76-$0.80 vs $1.07 Est

     Corteva (NYSE:CTVA) is looking for FY2026 Adj EPS of $0.76-$0.80 vs $1.07 analyst estimate..

103. ?Nov 11, 12:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

104. !Nov 11, 12:20 PMsignalseverity 0.18

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

105. ?Nov 11, 12:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

106. !Nov 11, 12:20 PMsignalseverity 0.18

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

107. ?Nov 11, 10:21 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

108. ?Nov 11, 10:21 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

109. !Nov 11, 10:21 AMsignalseverity 0.18

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

110. !Nov 11, 10:21 AMsignalseverity 0.18

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

111. ?Nov 11, 9:21 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

112. !Nov 11, 9:21 AMsignalseverity 0.17

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

113. ?Nov 11, 9:21 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

114. !Nov 11, 9:21 AMsignalseverity 0.17

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

115. ❖Nov 11, 8:37 AMnewsvia finnhub

     MMM Stock Climbed to an 8.5-Year High on a $7.35 Billion Forever Chemicals Settlement. The Overhang Could Finally Be Lifting.

     3M climbed to an 8.5-year high after announcing a $7.35 billion settlement over nine years to resolve most firefighting-foam personal-injury claims.

116. ❖Nov 11, 5:43 AMnewsvia finnhub

     Is Wall Street Bullish or Bearish on Vylor Stock?

     Despite Vylor's outperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

117. ❖Nov 11, 2:53 AMnewsvia finnhub

     Corteva Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

     Corteva will report Q3 earnings Nov. 11, with estimates of 10¢ EPS and $1.77B revenue.

118. ❖Nov 10, 7:45 PMnewsvia finnhub

     Moat Stocks Rebound As Tech Retreats

119. ?Nov 10, 7:31 PMdecisionconsidered

     Agent 4 — Dip Buyer (Frozen) — decide: skip

     CTVA (Corteva) is a fundamentally sound agricultural sciences company with a diversified seed and crop protection business, and there are no news headlines or SEC filings in the window indicating company-specific deterioration such as guidance cuts, accounting issues, or fraud. The 8-K filings contain no reported metrics, offering no clarity on what may have driven the ~18.6% drawdown from the 30-day high. The macro context highlights elevated mortgage rates (7.24%, 2.3σ above trend), which is more relevant to housing-sensitive sectors and does not directly pressure CTVA's agricultural business, leaving the cause of the drop somewhat ambiguous and potentially sentiment- or sector-rotation-driven.

120. !Nov 10, 7:31 PMsignalseverity 0.17

     Agent 4 — Dip Buyer (Frozen) — dip_skipped

     CTVA (Corteva) is a fundamentally sound agricultural sciences company with a diversified seed and crop protection business, and there are no news headlines or SEC filings in the window indicating company-specific deterioration such as guidance cuts, accounting issues, or fraud. The 8-K filings contain no reported metrics, offering no clarity on what may have driven the ~18.6% drawdown from the 30-day high. The macro context highlights elevated mortgage rates (7.24%, 2.3σ above trend), which is more relevant to housing-sensitive sectors and does not directly pressure CTVA's agricultural business, leaving the cause of the drop somewhat ambiguous and potentially sentiment- or sector-rotation-driven.

121. ?Nov 10, 2:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

122. !Nov 10, 2:20 PMsignalseverity 0.17

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

123. ?Nov 10, 2:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

124. !Nov 10, 2:20 PMsignalseverity 0.17

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

125. ?Nov 10, 1:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

126. !Nov 10, 1:20 PMsignalseverity 0.17

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

127. ?Nov 10, 1:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

128. !Nov 10, 1:20 PMsignalseverity 0.17

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

129. ?Nov 10, 12:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

130. !Nov 10, 12:20 PMsignalseverity 0.16

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

131. ?Nov 10, 12:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

132. !Nov 10, 12:20 PMsignalseverity 0.16

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

133. ?Nov 10, 11:20 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

134. !Nov 10, 11:20 AMsignalseverity 0.18

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

135. ?Nov 10, 11:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

136. ?Nov 9, 12:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

137. ?Nov 9, 12:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

138. ?Nov 9, 11:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

139. ?Nov 9, 11:20 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

140. ?Nov 9, 10:21 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

141. ?Nov 9, 10:21 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

142. ?Nov 9, 9:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

143. ?Nov 9, 9:20 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

144. ?Nov 9, 6:01 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

145. ?Nov 9, 6:01 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

146. ?Nov 6, 7:32 PMdecisionconsidered

     Agent 4 — Dip Buyer (Frozen) — decide: skip

     CTVA (Corteva) is a fundamentally sound agricultural sciences company with a diversified seed and crop protection business, and there are no news headlines or SEC filings in the window indicating company-specific deterioration such as guidance cuts, accounting issues, or fraud. The 8-K filings contain no reported metrics, offering no clarity on what may have driven the ~18.6% drawdown from the 30-day high. The macro context highlights elevated mortgage rates (7.24%, 2.3σ above trend), which is more relevant to housing-sensitive sectors and does not directly pressure CTVA's agricultural business, leaving the cause of the drop somewhat ambiguous and potentially sentiment- or sector-rotation-driven.

147. ?Nov 6, 1:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

148. ?Nov 6, 1:21 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

149. ?Nov 6, 12:21 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

150. ?Nov 6, 12:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CTVA is down 15.9% from its 30-day high with no news headlines to explain the drop, suggesting macro/sector pressure rather than a confirmed fundamental impairment — the company remains a major agricultural sciences player. However, earnings are imminent (7 days away, Nov 11) with a consensus EPS of just $0.03, creating a high-stakes binary event that dominates the near-term risk picture. Insider activity shows only equity award grants (not open-market purchases) to directors, which is routine compensation rather than a bullish signal. Options flow is muted and below average (z-scores both negative), providing no confirmation of informed buying interest.

151. ?Nov 6, 11:21 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     A hard veto fires immediately: earnings are imminent in 7 days (2026-11-11), and none of the three override conditions are satisfied simultaneously. Insider activity consists entirely of routine director equity awards (not open-market cluster purchases), call flow is below average (z=-0.55), and the fundamental picture is opaque given three metrics-empty 8-Ks and no 10-Q data. The stock's 15.9% drop from its 30-day high would otherwise be a mean-reversion candidate, and the sector has been outperforming SPY on both a 5d and 30d basis, suggesting this is an idiosyncratic single-stock move rather than broad sector weakness — a negative signal. With a near-zero consensus EPS of $0.03 and no visibility into what drove the selloff, the binary earnings event in one week makes the risk/reward structurally unattractive for a 90-day swing thesis.

152. ❖Oct 1, 7:30 AMnewsvia finnhub

     Corteva Announces Expiration and Final Results of Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033

     Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has received the final results of its previously announced (i) private offers to exchange (with respect to each series, an "Exchange Offer" and together, the "Exchange Offers") any and all of the outstanding senior notes of the series listed in the table below issued by EIDP, Inc., a Delaware corporation and a wholly owned subsidiary of Corteva ("EIDP" and such notes, col

153. ▣Sep 30, 8:00 PMjournalstop

     Agent 5 — Dip Buyer (Evolving) closed long 1 @ $13.90 (-$67.50)

     intraday stop sweep

154. ▣Sep 30, 8:00 PMjournalstop

     Agent 4 — Dip Buyer (Frozen) closed long 13 @ $13.90 (-$842.53)

     intraday stop sweep

155. ❖Sep 30, 8:46 AMnewsvia finnhub

     Dear Corteva Stock Fans, Mark Your Calendars for Oct. 1

     Corteva is about to officially spin off its seed genetics business

156. ❖Sep 30, 8:30 AMnewsvia finnhub

     Corteva Announces Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033

     Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has extended the expiration date of each of its previously announced (i) private offers to exchange (with respect to each series, an "Exchange Offer" and together, the "Exchange Offers") any and all of the outstanding senior notes of the series listed in the table below issued by EIDP, Inc., a Delaware corporation and a wholly owned subsidiary of Corteva ("EIDP" and such

157. ❖Sep 29, 6:41 AMnewsvia finnhub

     Jim Cramer Is Not Going To Go With This Consumer Cyclical Stock

     Cramer avoids Polaris, likes Forgent despite its valuation, finds Symbotic too expensive, and hasn’t reviewed Corteva; all four stocks fell.

158. ❖Sep 28, 1:16 PMnewsvia finnhub

     Corteva to End Pesticides Loyalty Program in Settlement With FTC

     Corteva (CTVA) will dismantle its existing pesticides loyalty program under a settlement agreement r

159. ❖Sep 28, 12:45 PMnewsvia finnhub

     Corteva and Inari Reach Settlement Agreement

     Corteva, Inc. (NYSE: CTVA) and Inari, the SEEDesign™ company, announced they have reached a confidential settlement agreement to resolve the lawsuit filed by Corteva in September 2023 that was pending in the United States District Court for the District of Delaware. As part of the settlement, Inari has agreed to destroy Corteva material it accessed from seed depositories and material developed from the deposits and assign to Corteva the intellectual property related to its edited versions of Cor

160. ❖Sep 28, 10:54 AMnewsvia finnhub

     AVO's Avocado Volumes Surge: Can Strong Growth Momentum Continue?

     Mission Produce's avocado volumes jump 38% as Calavo, stronger sourcing flexibility and robust consumer demand fuel fiscal third-quarter momentum.

161. ❖Sep 28, 9:18 AMnewsvia finnhub

     Can the Seeds Spin-Off Unlock Hidden Value in Corteva (CTVA)?

     Cooper Investors, an investment management firm, released its second-quarter 2026 investor letter for “Cooper Investors Global Equities Fund (Unhedged)”. The letter can be downloaded here. The Fund returned 6.6% for the quarter, bringing its financial-year return to -6.4%. On a local currency basis, performance was approximately flat for the year, as the strengthening Australian Dollar […]

162. ❖Sep 28, 4:39 AMnewsvia finnhub

     FTC And States Attorneys General Announce Settlement With Corteva Barring Pesticide Loyalty Programs For 10 Years, Corteva To Pay States $35M

     https://www.ftc.gov/news-events/news/press-releases/2026/09/ftc-states-win-protections-lower-pesticide-prices-american-farmers-antitrust-case-against-corteva

163. ❖Sep 27, 9:08 AMnewsvia finnhub

     3 US Agriculture Stocks Investors Are Watching After China Tariff Cuts

     When Washington and Beijing agree to trim tariffs on US$30b of goods each way, the story is not just about diplomacy; it is about containers of grain, soybeans and meat that suddenly face fewer hurdles on the way to Chinese ports. Investors who ignore that shift risk missing how it might reshape earnings power across US agricultural exporters. This article walks through three US agriculture stocks exposed to the tariff news, explaining how the new rules of trade could matter for your...

164. ❖Sep 24, 10:25 PMnewsvia finnhub

     Corteva Announces Effectiveness of Vylor's Form 10 Registration Statement

     Corteva (NYSE: CTVA) today announced that the U.S. Securities and Exchange Commission has declared effective Vylor's Registration Statement on Form 10. The Form 10 includes information regarding the business, strategy and priorities for Vylor, as well as details about the separation of Vylor into an independent, publicly traded company, which is expected to be completed on October 1, 2026. The Form 10 can be found on Corteva's website at: SEC Filing | Corteva Agriscience.

165. ❖Sep 23, 9:56 AMnewsvia finnhub

     ADM vs. CTVA: Two Agricultural Leaders With Very Different Moats

     Archer-Daniels-Midland and Corteva showcase contrasting agricultural models, from infrastructure-led scale to proprietary seeds, crop protection and innovation.

166. ❖Sep 21, 11:54 AMnewsvia finnhub

     US Diesel Prices Surge Past $6.50: The Agriculture ETFs Caught in the Crossfire

     U.S. diesel prices hit a record $6.50 a gallon, putting fresh pressure on farmers. Here’s what soaring fuel costs could mean for agriculture ETFs.

167. ❖Sep 21, 9:30 AMnewsvia finnhub

     Mission Produce's Blueberry Business: A Hidden Opportunity?

     AVO's expanding blueberry acreage in Peru could boost seasonal earnings, cash generation and diversification as newer plantings mature.

168. ❖Sep 21, 7:00 AMnewsvia finnhub

     Vylor and Rainbow Crops Partner to Accelerate Development of Novel Gene-Edited Corn Traits

     Vylor, the advanced seed and genetics company that will spin off from Corteva on October 1, 2026, and Rainbow Crops, a Belgium-based spin off from VIB, have announced a collaboration to advance new corn traits using artificial intelligence (AI) and multiplex gene editing, which enables scientists to edit multiple genes in a cell simultaneously.

169. ❖Sep 19, 2:37 PMnewsvia finnhub

     Corteva (CTVA) Bets On A Belgian Partner For Crop Protection’s Next Act

     On September 9, Corteva (NYSE:CTVA) and Belgium’s Globachem N.V. announced a definitive agreement to form a 50/50 joint venture aimed at developing and commercializing new crop protection products for farmers in Europe and the Americas. The timing matters. Corteva’s crop protection business is set to spin off as a standalone public company, Vylor, on October […]

170. ❖Sep 18, 5:06 AMnewsvia finnhub

     Argus Research Reiterates Buy on Corteva, Maintains $91 Price Target

     Argus Research analyst Alexandra Yates reiterates Corteva (NYSE:CTVA) with a Buy and maintains $91 price target.

171. ❖Sep 18, 3:16 AMnewsvia finnhub

     Zacks Industry Outlook Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and Dole

     Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and Dole have been highlighted in this Industry Outlook article.

172. ▢Sep 17, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 1 @ $81.40

173. ❖Sep 17, 10:40 AMnewsvia finnhub

     5 Agriculture Operations Stock Picks to Tap Long-Term Growth Trends

     The Agriculture - Operations industry is positioned to tap innovation, automation and shifting food demand despite persistent cost and commodity pressures. CTVA, ADM, SMG, AVO and DOLE look promising.

174. ❖Sep 17, 6:09 AMnewsvia finnhub

     Did Chemours' (CC) US$455 Million PFAS Deal Just Reframe Its Long‑Term Liability Narrative?

     On September 9, 2026, Chemours, DuPont, and Corteva reached a settlement with North Carolina and 11 nearby local entities, agreeing to pay US$455 million over 15 years to resolve PFAS-related claims tied to Chemours’ Fayetteville Works facility and other contamination issues. The agreement not only clears a significant portion of Chemours’ legacy PFAS exposure but also introduces a shared, net-present-value framework under the companies’ existing US$4.00 billion cost-sharing cap, potentially...

175. ❖Sep 17, 5:42 AMnewsvia finnhub

     Citigroup Maintains Neutral on Corteva, Raises Price Target to $91

     Citigroup analyst Patrick Cunningham maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $86 to $91.

176. ❖Sep 16, 11:40 AMnewsvia finnhub

     DOLE vs. CTVA: Which Stock Is the Better Value Option?

     DOLE vs. CTVA: Which Stock Is the Better Value Option?

177. ❖Sep 16, 9:01 AMnewsvia finnhub

     Corteva, Inc. (CTVA) Analyst/Investor Day Transcript

     Corteva, Inc. (CTVA) Analyst/Investor Day September 15, 2026 9:00 AM EDTCompany ParticipantsKimberly Booth - Vice President of Investor RelationsCharles...

178. ▢Aug 31, 8:00 PMjournal

     Agent 7 — Day Trader opened long 33 @ $87.33

179. ▣Aug 31, 8:00 PMjournaltime_stop

     Agent 7 — Day Trader closed long 33 @ $87.62 (+$9.74)

     EOD forced close — day trader never carries overnight

180. ▢Jul 30, 8:00 PMjournal

     Agent 4 — Dip Buyer (Frozen) opened long 13 @ $78.71

181. ▣Jul 23, 8:00 PMjournalexpired_settlement

     options_momentum closed long 140 @ $10.25 (+$1,173.48)

     SETTLED 2026-09-17 (mig 257): contract expired 2026-07-24 while the agent was disabled; settled at intrinsic 10.2500 from underlying close 89.25 (Massive, unadjusted). Was carried at stale 7/2 mark 7.0455.

182. ▣Jul 5, 8:00 PMjournaltarget

     Agent 4 — Dip Buyer (Frozen) closed long 15 @ $86.38 (+$157.80)

     Target hit: close $86.38 ≥ target $84.32

183. ▣Jun 25, 8:00 PMjournaltarget

     options_momentum closed long 60 @ $3.91 (+$122.66)

     De-risk: premium $3.91 ≥ 2.0× entry $1.87. Selling 60/200 contracts; trailing the remainder.

184. ▢Jun 17, 8:00 PMjournal

     options_momentum opened long 60 @ $1.87

185. ▢Jun 17, 8:00 PMjournal

     options_momentum opened long 140 @ $1.87

186. ▢Jun 16, 8:00 PMjournal

     options_momentum opened long 200 @ $1.65

187. ▣Jun 16, 8:00 PMjournalstop

     options_momentum closed long 200 @ $1.19 (-$91.86)

     Stop: premium $1.19 ≤ trailing floor $1.24 (peak $1.65 × 0.75)

188. ▢Jun 7, 8:00 PMjournal

     Agent 4 — Dip Buyer (Frozen) opened long 15 @ $75.86

189. ▣May 26, 8:00 PMjournalstop

     options_momentum closed long 300 @ $1.61 (-$222.37)

     Stop: premium $1.61 ≤ trailing floor $1.77 (peak $2.36 × 0.75)

190. ▢May 19, 8:00 PMjournal

     options_momentum opened long 300 @ $2.35

191. ▣May 18, 8:00 PMjournalstop

     options_momentum closed long 400 @ $0.72 (-$772.08)

     Stop: premium $0.72 ≤ trailing floor $1.99 (peak $2.65 × 0.75)

192. ▢May 13, 8:00 PMjournal

     options_momentum opened long 400 @ $2.65